Natco Pharma to acquire 35.75% stake in South Africa's Adcock Ingram for Rs 2,000 crore, marking its entry into the African ...

NATCO Pharma has announced a R4. 2 billion bid to acquire Adcock Ingram, significantly impacting the South African ...

Natco Pharma to acquire 35.75% stake in South Africa’s Adcock Ingram for ₹1,970 crore in cash; move aimed at expanding global ...

Natco Pharma on July 23 said it will buy 35.75% stake in South Africa's Adcock Ingram for Rs 2,000 crore. Natco Pharma to set ...

Hyderabad: NATCO Pharma Limited has submitted a firm intention offer to Adcock Ingram Holdings Limited, a South African ...

Adcock Ingram offers generics and OTC medicines in Africa. CNBC-Awaaz reported that Natco may buy majority stake in the firm ...

The deal will still see Bidvest as the majority shareholder but will mean that the SA pharmaceutical group will be delisted ...

Natco Pharma has proposed to acquire a 35.75% stake in South African Adcock Ingram Holdings for Rs 2,100 crore. This move ...

Natco Pharma to acquire 36% stake in Adcock Ingram Holdings for $226 million, expanding presence in South Africa.

Natco Pharma Ltd said on Monday it has agreed a deal with Gilead Sciences Inc to supply generic copies of the U.S. drugmaker's chronic hepatitis C medicines, including $1,000-a-pill drug Sovaldi ...

Natco Pharma Ltd. on Wednesday, July 23, announced the acquisition of a 35.75% stake in South Africa-based Adcock Ingram ...

Natco’s proposed all-cash deal to acquire nearly 36% of AIHL from minority shareholders is aimed at expanding its presence in ...